Recent Quotes
My Watchlist
Indicators
REW 40 Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Collegium Pharmaceutical, Inc. - Common Stock (NQ:COLL)

29.83 +0.23 (+0.78%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 669,952
Open 29.82
Bid (Size) 28.89 (1)
Ask (Size) 30.00 (10)
Prev. Close 29.60
Today's Range 29.24 - 29.97
52wk Range 23.23 - 42.29
Shares Outstanding 32,250,236
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Abuse Deterrent Formulations Market Exploding While Estimated to Reach $39 Million In 2025 and $54 Million By 2030
EQNX::TICKER_START (NASDAQ:NTRB),(NASDAQ:NTRBW),(NYSE:PFE),(NASDAQ:COLL),(NYSE:TEVA),(NYSE:EBS) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Death
Exposures Death
1 Russell 2000 Stock on Our Watchlist and 2 to Keep Off Your Radar
The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the... 
Via StockStory

Performance

YTD
+4.2%
+4.2%
1 Month
+1.2%
+1.2%
3 Month
-0.7%
-0.7%
6 Month
+0.4%
+0.4%
1 Year
-5.5%
-5.5%

More News

Read More
Earnings Scheduled For May 8, 2025
Via Benzinga
Abuse Deterrent Formulations Market Exploding While Estimated to Reach $39 Million In 2025 and $54 Million By 2030
From FN Media Group LLC
Via GlobeNewswire
COLL Q1 Earnings Call: ADHD Portfolio Drives Growth, Management Details Capital Deployment Priorities
Via StockStory
3 of Wall Street’s Favorite Stocks with Mounting Challenges
Via StockStory
Branded Pharmaceuticals Stocks Q1 In Review: Collegium Pharmaceutical (NASDAQ:COLL) Vs Peers
Via StockStory
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
1 Stock Under $50 with Exciting Potential and 2 to Turn Down
Via StockStory
Collegium to Participate in Upcoming Investor Conferences
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
3 Small-Cap Stocks Facing Headwinds
Via StockStory
Collegium Announces $25 Million Accelerated Share Repurchase Program
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Collegium Pharmaceutical (NASDAQ:COLL) Exceeds Q1 Expectations
Via StockStory
Collegium Reports First Quarter 2025 Financial Results and Highlights Recent Company Progress
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Collegium Pharmaceutical (COLL) Q1 Earnings: What To Expect
Via StockStory
3 Healthcare Stocks That Concern Us
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities
Collegium to Report First Quarter 2025 Financial Results on May 8, 2025
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
2 Reasons to Watch COLL and 1 to Stay Cautious
Via StockStory
What Analysts Are Saying About Collegium Pharmaceutical Stock
Via Benzinga
A Look Back at Branded Pharmaceuticals Stocks’ Q4 Earnings: Collegium Pharmaceutical (NASDAQ:COLL) Vs The Rest Of The Pack
Via StockStory
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
Collegium to Participate in 24th Annual Needham Virtual Healthcare Conference
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Collegium to Present Real-World Data at PainConnect 2025, the American Academy of Pain Medicine’s Annual Meeting
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board
From Avalo Therapeutics
Via GlobeNewswire
Forecasting The Future: 4 Analyst Projections For Collegium Pharmaceutical
Via Benzinga
Q4 Earnings Highs And Lows: Royalty Pharma (NASDAQ:RPRX) Vs The Rest Of The Branded Pharmaceuticals Stocks
Via StockStory
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
Collegium Announces Updates to its Board of Directors and Executive Leadership Team
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Collegium Pharmaceutical, Inc. - Common Stock publicly traded?
Yes, Collegium Pharmaceutical, Inc. - Common Stock is publicly traded.
What exchange does Collegium Pharmaceutical, Inc. - Common Stock trade on?
Collegium Pharmaceutical, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Collegium Pharmaceutical, Inc. - Common Stock?
The ticker symbol for Collegium Pharmaceutical, Inc. - Common Stock is COLL on the Nasdaq Stock Market
What is the current price of Collegium Pharmaceutical, Inc. - Common Stock?
The current price of Collegium Pharmaceutical, Inc. - Common Stock is 29.83
When was Collegium Pharmaceutical, Inc. - Common Stock last traded?
The last trade of Collegium Pharmaceutical, Inc. - Common Stock was at 06/20/25 04:00 PM ET
What is the market capitalization of Collegium Pharmaceutical, Inc. - Common Stock?
The market capitalization of Collegium Pharmaceutical, Inc. - Common Stock is 962.02M
How many shares of Collegium Pharmaceutical, Inc. - Common Stock are outstanding?
Collegium Pharmaceutical, Inc. - Common Stock has 962M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.